Mediseek
en_ENfr_FR

Browse by alphabet

0 1 2 3 4 5 6 7 8 9
A B C D E F G H I
J K L M N O P Q R
S T U V W X Y Z

Common search terms

- ecchymosis
- embryonary
- thymidylate synthase
- nisoldipine
- genital herpes simplex
- caproyl
- calcitonin salmon injection
- interbrain
- oesophageal dysrhythmia
- xiphisternal joint
- working occlusion
- ca2
- neck injuries
- myopia
- penicillanic acid
- dextromethorphan
- secretor
- encephalomyelitis virus, avian
- active immunity
- postural vertigo
 
Pages for yttrium-90
11
 

CDC Radiation Emergencies |Prenatal Radiation Exposure: A Fact Sheet for Physicians

... For substances that can localize in specific organs and tissues in the fetus, such as iodine-131 or iodine-123 in the thyroid, iron-59 in the liver, gallium-67 in the spleen, and strontium-90 and yttrium-90 in the...
http://www.bt.cdc.gov/radiation/prenatalphysician.asp
12
 

eMedicine - Insulinoma : Article by Zonera Ashraf AlieMedicine - Insulinoma : Article by

Home / Specialties / Reference Centers / All Sources eMedicine Medscape Drug Reference MEDLINE / Quick Find / Authors & Editors / Introduction / Clinical / Differentials / Workup / Treatment / Medication / Follow-up / Miscellaneous / References...
http://www.emedicine.com/med/topic2677.htm
13
 

90Y-Ibritumomab tiuxetan (Zevalin®) : Cancerbackup

Cancerbackup: 90Y-Ibritumomab tiuxetan ... Radioisotopes are chemicals that give off energy in the form of radiation. Zevalin is a monoclonal antibody that is combined with the radioisotope Yttrium-90 (90Y) (pronounced...
http://www.cancerbackup.org.uk/Treatments/Biologicaltherapies/Monoclonalantibodies/90Y-Ibritumomabtiuxetan
14
 

e-Prints Soton - Antibody therapy of lymphoma

Antibody therapy of lymphoma ... The availability of rituximab and the possible imminent availability of two new radiolabelled monoclonal anti-CD20 antibodies (Yttrium-90 (90Y)-ibritumomab and Iodine-131(131I)-tositumomab)...
http://eprints.soton.ac.uk/26392/
15
 

BIOPHARMA FDA Approvals

... [Ibritumomab Tiuxetan; Zevalin; a CD20 monoclonal antibody-chelating group conjugate] - granted on 2/29/2002 to IDEC Pharmaceuticals Corp. for treatment of B-cell non-Hodgkin's lymphoma; regimen includes Rituximab, Indium-111 Ibritumomab...
http://www.bioportfolio.com/BioPharma/BIOPHARMA_FDA_Approvals.htm
16
 

Healthopedia.com - Detailed Drug Information (USP DI) - I-Int - (Drugs & Medications)

Set Homepage Email Page Favorites / Home / Health Centers / Medical Encyclopedia / Drugs & Medications / Diseases & Conditions / Medical Symptoms / Medical Tests & Exams / Surgery & Procedures / Injuries & Wounds / Diet &...
http://www.healthopedia.com/drugs/detailed/index-i.html
17
 

: The AMEDEO Literature Guide

Home Casteddu.com FAQ My Amedeo About Flying Publisher / Serving > 100.000 scientists every week / Biliary Tract Diseases / Free Subscription / Articles published in Cancer ... Treatment of unresectable cholangiocarcinoma using...
http://www.amedeo.com/medicine/btd/canc.htm
18
 

Sarah Houlton - published articles

Could MAbs be the 'magic bullet'? Manufacturing Chemist, September 2005 ... Zevalin combines a MAb directed at the CD20 antigen with the radioisotope yttrium-90. ... The yttrium-90 has a half life of...
http://www.users.globalnet.co.uk/~sarahx/articles/mcmabs.htm
19
 

New Device Approval

FDA Home Page | CDRH Home Page | / Search | / CDRH A-Z Index | / Contact CDRH / New Device Approval / SIR-Spheres®- P990065 ... What is it? SIR-Spheres® consists of tiny spheres of yttrium-90, a radioactive substance, that...
http://www.fda.gov/cdrh/mda/docs/P990065.html
20
 

Nuclear Medicine Applications More Than "Atomic Cocktails"

Top Stories / Nuclear Medicine Applications More Than "Atomic Cocktails" ... Promising advances also are seen in targeted therapy for cancer management where the need for therapeutic radioisotopes - such as lutetium-77 and...
http://www.iaea.org/PrinterFriendly/NewsCenter/News/2005/radiopharmaceuticals.html
 
 
 
< | 1 | 2 | 3 | 4 | 5 | 6 | 7 | >
 
 
Helpful links | About Mediseek | Company | Privacy policy | Contact
Vertical portal made by
www.seekport.biz

© 2007, Seekport Internet Technologies UK Ltd
Seekport Internet Technologies GmbH